ChronoScale Corp Announces $1 Billion Revenue Run‑Rate Target
Chronoscale Corp (NASDAQ:CHRN), a Menlo Park, California‑based accelerated compute platform provider, disclosed that a contract extension with an existing AI infrastructure customer and a new agreement with a second AI customer will together with its existing contracts and current deployment schedule generate an annualized revenue run‑rate of $1 billion by the third quarter of calendar 2027. The company highlighted that this revenue milestone is contingent on the successful and timely deployment of planned infrastructure capacity, the availability of power and equipment, and the firm’s ability to secure capital on acceptable terms.
Market Reaction
Following the announcement, Chronoscale’s shares rose approximately 3 % in after‑hours trading on Thursday, indicating investor confidence in the projected revenue growth.
Strategic Focus Shift
Chronoscale also completed the divestiture of its Ekso Bionics business unit. Management indicated that the sale will allow the company to concentrate its operations and capital allocation on its core accelerated compute and AI infrastructure business.
Corporate Background
Chronoscale was formed through the strategic combination of Applied Digital’s cloud business and EKSO Bionics Holdings, Inc. It now operates as an independent public entity focused on scalable GPU‑based infrastructure optimized for AI training, inference, and high‑performance computing. The platform is designed to meet growing enterprise and AI‑native demand for dedicated computing environments capable of handling demanding AI workloads.
Executive Commentary
Chief Executive Officer Cenly Chen stated, “With these agreements, together with our existing contracts and current deployment schedule, we now have agreements in place that provide for $1 billion in annualized revenue run‑rate during calendar 2027.” He also cautioned that the achievement and timing of the contracted revenue remain subject to the risks outlined above.